Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1970-1974  (4)
  • Kininogens  (2)
  • Pharmacokinetics  (2)
  • Acetylcholine
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 276 (1973), S. 327-340 
    ISSN: 1432-1912
    Keywords: Tetanus Toxin ; Pharmacokinetics ; Central Nervous System ; Iodine Labelling ; Receptors
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary In order to understand the symptomatology of generalized tetanus from the pharmacokinetics of the toxin, 125I-labelled toxin was injected i.v. in rats without and with antitoxin. 1. After a few hours latency, brain stem and spinal cord concentrate radioactive material up to the third day. The decline of radioactivity is very slow, semilogarithmic, and can be followed up to the 24th day after injection. In contrast, forebrain and cerebellum do not bind measurable radioactivity. Less than 1% of the radioactivity injected is found in the CNS. 2. The symptoms of tetanus start some time after the bulk of labelled toxin has been taken up by the CNS. They cease before all radioactivity has left it. 3. Antitoxin, given simultaneously, prevents the onset of symptoms and the uptake of radioactivity by the CNS. When given 10 h after labelled toxin, it nearly abolishes the fixation and still prevents the onset of symptoms. When given 48 h after toxin, it is nearly ineffective in both respects. Antitoxin first delays, then enhances the elimination of labelled toxin from the blood. 4. Labelled antitoxin is not enriched in the CNS. 5. The uptake of radioactivity into various parts of spinal cord corresponds well to their relative content in grey matter. 6. The pharmacokinetic behaviour of 125I-toxoid resembles that of toxin. However, in order to get measurable fixation to the CNS at least 50 times higher amounts are to be applied. It is concluded that the barrier between blood and CNS is practically impermeable to tetanus toxin. The results can be harmonized best with the assumption that generalized tetanus is nothing else than a multiple local tetanus.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 269 (1971), S. 101-111 
    ISSN: 1432-1912
    Keywords: Kininogens ; Kallikreins ; Bradykinin ; Hageman Factor
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Sephadex G 200 chromatography of non-contacted human or bovine plasma reveals one peak of kininogen (LMW kininogen) which serves as substrate for both trypsin and contact kallikrein (= prekallikrein activated by Hageman Factor.) 2. Under special conditions (faster flow rate, protection with diisopropyl fluorophosphate and hexadimethrine bromide), a small kininogen fraction of higher molecular weight (HMW) occasionally preceded the LMW substrate. It appeared increased when the plasma was hemolytic whether contacted or not. 3. Native human plasma was subjected to DEAE sephadex chromatography using stepwise elution starting with relatively high salt concentration. The second peak called HMW-kininogen emerged together with the abrupt increase in ionic strength and contained 2.2 to 4.8 times less kinin than did the first. Both kininogens yielded kinin with purified contact kallikrein. 4. By analytical gel filtration of different HMW-kininogen preparations, molecular weights of about 100,000, 200,000 and 500,000 were estimated. We conclude that HMW-kininogen is not represented by a distinct, individual molecule. It may be a polymer of the low molecular weight kininogen or an aggregate of it with other plasma constituents.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 269 (1971), S. 85-100 
    ISSN: 1432-1912
    Keywords: Kininogens ; Kallikreins ; Bradykinin ; Protease Inhibitors ; Hageman Factor
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary 1. Prekallikrein, prepared according to Nagasawaet al., has been purified further by agarose gel electrophoresis. It can be activated directly by Hageman factor and by solid phase trypsin. Its specific activity (benzoyl arginine ethyl ester as substrate) was 13.2 μM min−1 mg−1. Gel filtration on a calibrated column of sephadex G 200 revealed a molecular weight of 101,000, which is close to the value reported for casein-activated kallikrein. 2. The contact-activated bovine enzyme was very similar to casein-activated porcine kallikrein. Both enzymes hydrolyzed benzoyl arginine ethyl ester and tosylarginine methyl ester with about the same speed. The sensitivity of the two preparations against trasylol®, soy bean inhibitor, and serum inhibitor was also not different. 3. In contrast to previous assumptions, purified bovine LMW kininogen (MW 50,000) proved to be substrate for contact-activated kallikrein. As with the caseinactivated enzyme, the total bradykinin content of the kininogen could be released. 4. Serum, even when heated previously to 61°C, contains inhibitors against kallikreins activated by contact or casein, as well as against trypsin. Whereas pretreatment according to Diniz and Carvalho (pH about 2; 98°C) renders the serum more susceptible to trypsin, such denaturated substrate is less accessible for both kallikreins. Serum or plasma pretreated according to Horton (pH2; 37°C), yield at least 50% of the kinin activity obtained with trypsin, irrespective of the kallikreins used. 5. When acid-treated (according to Horton) 61°-serum has been incubated first with casein-activated kallikrein, contact-activated enzyme does not release additional kinin activity and vice versa. 6. Plasma which has been rotated exhaustively with glass, nevertheless contains substrate for contact-activated kallikrein. 7. Addition of Hageman factor to Horton's substrate does not increase the kinin yield above that obtained by glass-contact of normal plasma. Addition of prekallikrein, however, increases the kinin yield about threefold. Therefore, neither Hageman factor nor substrate, but the actual amount of active kallikrein limits the kinin yield upon glass activation. 8. Our experiments with serum kallikreins and their substrates can be interpreted without assuming a distinct, contact activated kinin system.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 273 (1972), S. 313-330 
    ISSN: 1432-1912
    Keywords: Snake Venom ; Phospholipase A ; Potentiation ; Iodine Labelling ; Pharmacokinetics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary In order to obtain better insight into the potentiation of the toxicity of phospholipase A by crotapotin, we studied the distribution and elimination of these substances and of their combination. Blood Plasma Concentration. Iodine-labelled phospholipase A leaves the bloodstream of mice and rabbits very quickly after i.v. application. Simultaneous injection of crotapotin speeds the elimination of the enzyme. After subcutaneous application in mice the plasma concentration of phospholipase A depends on the quantity of enzyme injected. It is higher when the enzyme is complexed with crotapotin before injection. The plasma concentration of phospholipase A fails, however, to be proportional to the toxicity of the complex after subcutaneous application. Crotapotin leaves the blood of mice also very quickly after i.v. application. Organ Distribution. After i.v. application in mice, phospholipase A is heavily enriched in the liver. By simultaneous application of crotapotin, the enzyme is partially diverted to the kidneys. Only a small percentage of injected enzyme is found in the brain. This percentage is just significantly raised by simultaneous application of crotapotin. The diaphragm contains about the twofold amount of phospholipase A per wet weight as compared with other samples of skeletal musculature. With crotapotin, there is a slight increase of the radioactivity in all muscles investigated, with different degrees of significance. Crotapotin is enriched in mouse kidneys after i.v. application. Renal Elimination. The renal elimination of the acidic crotapotin is higher than that of the basic phospholipase A. In this respect, the latter resembles the basic polypeptide Trasylol®. Doses of phospholipase A above 0.25 mg/kg cause intravital hemolysis. The hemolysis is prevented if a small amount of crotapotin is applied simultaneously. Our findings show that the combination with crotapotin distinctly alters the pharmacokinetic behaviour of Crotalus terrificus phospholipase A. However, our data do not explain the tremendous increase of phospholipase A toxicity caused by the non-toxic crotapotin.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...